查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1511838

药物筛检市场规模、份额、趋势分析报告：按产品类型、样本类型、最终用途、地区和细分市场预测，2024-2030 年

Drug Screening Market Size, Share & Trends Analysis Report By Product Type (Instruments, Rapid Testing Devices), By Sample Type (Urine Sample, Breath Sample), By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 125 Pages | 商品交期: 2-10个工作天内

价格

药物筛检市场成长与趋势：

Grand View Research, Inc.最新报告显示，到2030年，全球药物筛检市场规模预计将达到119.9亿美元，预测期内复合年增长率为4.0%。

这个市场是由对准确检测药物滥用的需求推动的，而这种需求是由日益增加的职场安全问题、监管反应和测试方法的技术进步所驱动的。

英格兰接触毒品和酒精服务的成年人数量从2020-2021年的275,896人增加到2021-2022年的289,215人，增加了4.8%，这是该国毒品滥用现象的最大增幅。药物滥用盛行率的上升进一步支持了有效预防和治疗策略的必要性，包括扩大获得循证治疗方案的机会以及提高对药物和酒精滥用风险的认识的公共卫生宣传活动。

同样，2020年美国12岁及以上非法药物使用流行率约为3731万人，较过去几年与前一年同期比较增长3.8%，这种流行率的上升是市场的一个重要因素。这一增加凸显了职场、学校和医疗机构迫切需要开展全面的药物筛检计划，以确保安全、遵守法规，并为那些与药物滥用作斗争的人们提供适当的护理和支持。

此外，新产品推出、合併和收购等市场参与者的倡议也促进了市场的成长。例如，2024 年 2 月，纽约领先的药物检测提供者 Mobile Health 为雇主推出了快速药物检测，一小时内即可得出结果。这项创新专注于高精度和多功能的尿液测试，推进了招募流程并彻底改变了纽约的人才招募。此外，FDA 将在 2023 年 12 月核准AvertD 测试，该测试透过基因标记评估个人罹患鸦片类药物使用障碍的风险，这标誌着对抗鸦片类药物危机的重大创新。该测试由 AutoGenomics 开发，旨在在患者首次接触口服阿片类止痛药物之前使用，特别是计划进行手术的患者。该测试旨在帮助患者和医疗保健提供者就阿片类药物的使用做出明智的决定，并降低成瘾和滥用的风险。

AvertD 的核准是 FDA 解决阿片类药物危机的更广泛努力的一部分，包括 2022 年 8 月推出 FDA过量摄取预防框架以及 2023 年 3 月和 7 月核准非处方纳洛酮滴鼻剂。 FDA 对解决这场危机的承诺体现在我们对开发有助于评估和降低阿片类药物使用障碍风险的医疗设备的持续支持。

药物筛检市场报告亮点

  • 按产品类型划分，消耗品在 2023 年占据了收益最快的市场占有率，并且由于主要企业将采取广泛的研发倡议，预计在预测期内将以最快的速度增长。
  • 按类型划分，尿液样本占据最大的收益占有率，并在 2023 年占据市场主导地位。尿液药物检测通常比其他检测方法（例如毛髮检测）更具成本效益。
  • 由于人们越来越关注药物滥用治疗和康復以及这些中心对药物检测服务的需求不断增加，药物治疗中心的最终用途部分将在 2023 年占据市场主导地位。
  • 由于先进的医疗基础设施、非法药物的高消费量以及职场药物检测的需求等因素，北美在全球市场中占据主导地位。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章药物筛检市场变数、趋势和范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场推动要素分析
    • 市场限制因素分析
  • 药物筛检市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析
    • 价格分析

第四章药物筛检市场：产品类型估计与趋势分析

  • 全球药物筛检市场：产品类型仪表板
  • 全球药物筛检市场：产品类型变化分析
  • 全球药物筛检市场：依产品类型、收益
  • 装置
  • 快速检测装置
  • 消耗品
  • 服务及更多

第五章药物筛检市场：技术评估与趋势分析

  • 全球药物筛检市场：样品类型仪表板
  • 全球药物筛检市场：样本类型变异分析
  • 全球药物筛检市场：依样本类型、按收益
  • 尿液样本
  • 呼吸样本
  • 口腔液样本
  • 头髮样本
  • 其他样品

第六章药物筛检市场：最终用途估计与趋势分析

  • 全球药物筛检市场：最终用途仪表板
  • 全球药物筛检市场：最终用途变异分析
  • 全球药物筛检市场：依最终用途、按收益
  • 医院
  • 刑事司法和执法
  • 职场
  • 戒毒治疗中心
  • 个人用户
  • 疼痛管理中心
  • 学校和大学
  • 其他的

第七章药物筛检市场：按产品类型、样本类型和最终用途进行的区域估计和趋势分析

  • 区域仪表板
  • 2018-2030年市场规模、预测趋势分析
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第八章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争对手分类
  • 供应商情况
    • 主要经销商及通路伙伴名单
    • 主要客户
    • 2023年主要企业市场占有率分析
    • Abbott
    • Quest Diagnostics Incorporated
    • F. Hoffmann-La Roche Ltd
    • Thermo Fisher Scientific Inc.
    • Siemens Healthcare AG
    • Laboratory Corporation of America Holdings
    • Alfa Scientific Designs, Inc.,
    • OraSure Technologies, Inc.
    • Omega Laboratories, Inc.
    • Dragerwerk AG &Co. KGaA
    • Bio-Rad Laboratories, Inc.
Product Code: GVR-4-68040-303-9

Drug Screening Market Growth & Trends:

The global drug screening market size is anticipated to reach USD 11.99 billion by 2030 and is growing at a CAGR of 4.0% during the forecast period, according to a new report by Grand View Research, Inc. The market is driven by increasing workplace safety concerns, regulatory compliance, and requirement for accurate detection of substance abuse, aided by technological advancements in testing methods.

The increase in number of adults in contact with drug and alcohol services in England has increased from 275,896 in 2020 - 2021¬ to 289,215 in 2021 - 2022, representing a 4.8% rise, which signifies a growing prevalence of substance abuse in the country. The rising prevalence of substance abuse further propels the need for effective prevention and treatment strategies, including the expansion of access to evidence-based treatment options and public health campaigns to raise awareness about the risks of drug and alcohol misuse.

Similarly, the incidence of illegal substance use among Americans aged 12 and older in 2020 was around 37.31 million, and shows a 3.8% year-over-year increase over the years; this rising prevalence serves as a significant driver for the market. This increase highlights the urgent need for comprehensive drug screening programs in workplaces, schools, and healthcare settings to ensure safety, compliance with regulations, and provision of appropriate care and support for individuals struggling with substance abuse.

Furthermore, initiatives by market players such as new product launches, mergers, acquisitions, and others contribute to market growth. For instance, in February 2024, Mobile Health, the leading drug testing provider in NYC, introduced rapid drug testing for employers, ensuring results in an hour or less. With a focus on urine-based testing for accuracy and versatility, this innovation advances the hiring process, revolutionizing talent acquisition in NYC. In addition, in December 2023, the FDA's approval of the AvertD test, which assesses an individual's risk of developing opioid use disorder through genetic markers, marks a significant innovation in the fight against the opioid crisis. This test, developed by AutoGenomics, Inc., is designed to be used before a patient is first exposed to oral opioid pain medications, particularly in patients scheduled for surgical procedures. The test is intended to help patients and healthcare providers make informed decisions about opioid use, potentially reducing the risk of addiction and misuse.

The approval of AvertD is part of FDA's broader efforts to address opioid crisis, which includes the introduction of FDA Overdose Prevention Framework in August 2022 and the approval of nonprescription naloxone nasal spray products in March and July 2023. The FDA's commitment to addressing these crisis is evident in its continued support for the development of medical devices that can help assess and mitigate the risk of opioid use disorder.

Drug Screening Market Report Highlights:

  • Consumables dominated the product type segment with the fastest revenue market share in 2023 and is anticipated to grow at fastest growth rate over the forecast period owing to extensive R&D initiatives undertaken by major players to develop kits
  • Based on type segment, urine sample dominated the market with the largest revenue share in 2023 attributed to the ease of collection. Urine drug testing is generally more cost-effective compared to other testing methods, such as hair testing
  • Drug treatment centers end-use segment dominated the market in 2023, attributed to the increasing focus on substance abuse treatment and rehabilitation, leading to a higher demand for drug testing services in these centers
  • North America dominated the global market owing to factors such as advanced healthcare infrastructure, the region's high consumption of illegal substances, and the necessity for workplace drug tests

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product Type
    • 1.2.2. Sample Type
    • 1.2.3. End-use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product type outlook
    • 2.2.2. Sample type outlook
    • 2.2.3. End-use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Drug Screening Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing drug and alcohol consumption
      • 3.2.1.2. Growing demand for drug screening measures
      • 3.2.1.3. Rise in government funding
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Rising false positive and negative results in drug screeni9ng limits screening process
      • 3.2.2.2. Rise in privacy concerns limiting the expansion of drug screening practices
  • 3.3. Drug Screening Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
    • 3.3.3. Pricing Analysis

Chapter 4. Drug Screening Market: Product Type Estimates & Trend Analysis

  • 4.1. Global Drug Screening Market: Product Type Dashboard
  • 4.2. Global Drug Screening Market: Product Type Movement Analysis
  • 4.3. Global Drug Screening Market by Product Type, Revenue
  • 4.4. Instruments
    • 4.4.1. Instruments market estimates and forecasts 2018 - 2030 (USD Million)
    • 4.4.2. Immunoassays Analyzers
      • 4.4.2.1. Market estimates and forecasts 2018 - 2030 (USD Million)
    • 4.4.3. Chromatography Instruments
      • 4.4.3.1. Market estimates and forecasts 2018 - 2030 (USD Million)
    • 4.4.4. Breath Analyzer
      • 4.4.4.1. Market estimates and forecasts 2018 - 2030 (USD Million)
      • 4.4.4.2. Fuel Cell Breath Analyzer
      • 4.4.4.2.1. Market estimates and forecasts 2018 - 2030 (USD Million)
      • 4.4.4.3. Semi-conductor Breath Analyzer
      • 4.4.4.3.1. Market estimates and forecasts 2018 - 2030 (USD Million)
      • 4.4.4.4. Others Breath Analyzer
      • 4.4.4.4.1. Market estimates and forecasts 2018 - 2030 (USD Million)
  • 4.5. Rapid Testing Devices
    • 4.5.1. Rapid testing devices market estimates and forecasts 2018 - 2030 (USD Million)
    • 4.5.2. Urine Testing Devices
      • 4.5.2.1. Market estimates and forecasts 2018 - 2030 (USD Million)
      • 4.5.2.2. Drug Testing Cups
      • 4.5.2.2.1. Market estimates and forecasts 2018 - 2030 (USD Million)
      • 4.5.2.3. Dip Cards
      • 4.5.2.3.1. Market estimates and forecasts 2018 - 2030 (USD Million)
      • 4.5.2.4. Drug Testing Cassettes
      • 4.5.2.4.1. Market estimates and forecasts 2018 - 2030 (USD Million)
    • 4.5.3. Oral Fluid Testing Devices
      • 4.5.3.1. Market estimates and forecasts 2018 - 2030 (USD Million)
  • 4.6. Consumables
    • 4.6.1. Consumables market estimates and forecasts 2018 - 2030 (USD Million)
    • 4.6.2. Assay Kits
      • 4.6.2.1. Market estimates and forecasts 2018 - 2030 (USD Million)
    • 4.6.3. Sample Collection Devices
      • 4.6.3.1. Market estimates and forecasts 2018 - 2030 (USD Million)
    • 4.6.4. Calibrators & Controls
      • 4.6.4.1. Market estimates and forecasts 2018 - 2030 (USD Million)
    • 4.6.5. Other Consumables
      • 4.6.5.1. Market estimates and forecasts 2018 - 2030 (USD Million)
  • 4.7. Services and Others
    • 4.7.1. Services and others market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 5. Drug Screening Market: Technology Estimates & Trend Analysis

  • 5.1. Global Drug Screening Market: Sample Type Dashboard
  • 5.2. Global Drug Screening Market: Sample Type Movement Analysis
  • 5.3. Global Drug Screening Market by Sample Type, Revenue
  • 5.4. Urine Samples
    • 5.4.1. Urine samples market estimates and forecasts 2018 - 2030 (USD Million)
  • 5.5. Breath Samples
    • 5.5.1. Breath samples market estimates and forecasts 2018 - 2030 (USD Million)
  • 5.6. Oral Fluid Samples
    • 5.6.1. Oral fluid samples market estimates and forecasts 2018 - 2030 (USD Million)
  • 5.7. Hair Samples
    • 5.7.1. Hair samples market estimates and forecasts 2018 - 2030 (USD Million)
  • 5.8. Other Samples
    • 5.8.1. Other samples market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 6. Drug Screening Market: End-use Estimates & Trend Analysis

  • 6.1. Global Drug Screening Market: End-use Dashboard
  • 6.2. Global Drug Screening Market: End-use Movement Analysis
  • 6.3. Global Drug Screening Market by End-use, Revenue
  • 6.4. Hospitals
    • 6.4.1. Hospitals market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.5. Criminal Justice & Law Enforcement Agencies
    • 6.5.1. Clinical laboratories market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.6. Workplaces
    • 6.6.1. Workplaces market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.7. Drug Treatment Centers
    • 6.7.1. Drug treatment centers market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.8. Individual Users
    • 6.8.1. Individual users market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.9. Pain Management Centers
    • 6.9.1. Pain management centers market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.10. Schools & Colleges
    • 6.10.1. Schools & Colleges market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.11. Others
    • 6.11.1. Others market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 7. Drug Screening Market: Regional Estimates & Trend Analysis by Product Type, Sample Type, and End-use

  • 7.1. Regional Dashboard
  • 7.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.3. North America
    • 7.3.1. U.S.
      • 7.3.1.1. Key country dynamics
      • 7.3.1.2. Regulatory framework/ reimbursement structure
      • 7.3.1.3. Competitive scenario
      • 7.3.1.4. U.S. market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.3.2. Canada
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Regulatory framework/ reimbursement structure
      • 7.3.2.3. Competitive scenario
      • 7.3.2.4. Canada market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.3.3. Mexico
      • 7.3.3.1. Key country dynamics
      • 7.3.3.2. Regulatory framework/ reimbursement structure
      • 7.3.3.3. Competitive scenario
      • 7.3.3.4. Mexico market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Regulatory framework/ reimbursement structure
      • 7.4.1.3. Competitive scenario
      • 7.4.1.4. UK market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework/ reimbursement structure
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. Germany market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.4.3. France
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework/ reimbursement structure
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. France market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Regulatory framework/ reimbursement structure
      • 7.4.4.3. Competitive scenario
      • 7.4.4.4. Italy market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Regulatory framework/ reimbursement structure
      • 7.4.5.3. Competitive scenario
      • 7.4.5.4. Spain market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.4.6. Denmark
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Regulatory framework/ reimbursement structure
      • 7.4.6.3. Competitive scenario
      • 7.4.6.4. Denmark market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.4.7. Sweden
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Regulatory framework/ reimbursement structure
      • 7.4.7.3. Competitive scenario
      • 7.4.7.4. Sweden market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.4.8. Norway
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Regulatory framework/ reimbursement structure
      • 7.4.8.3. Competitive scenario
      • 7.4.8.4. Norway market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/ reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. Japan market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.5.2. China
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. China market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.5.3. India
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. India market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework/ reimbursement structure
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Australia market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework/ reimbursement structure
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. South Korea market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.5.6. Thailand
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework/ reimbursement structure
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Thailand market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/ reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. Brazil market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.6.2. Argentina
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Argentina market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.7. MEA
    • 7.7.1. South Africa
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. South Africa market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Saudi Arabia market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. UAE market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Kuwait market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2023
    • 8.3.4. Abbott
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Quest Diagnostics Incorporated
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. F. Hoffmann-La Roche Ltd
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Thermo Fisher Scientific Inc.
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Siemens Healthcare AG
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Laboratory Corporation of America Holdings
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Alfa Scientific Designs, Inc.,
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. OraSure Technologies, Inc.
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Product benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. Omega Laboratories, Inc.
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Product benchmarking
      • 8.3.12.4. Strategic initiatives
    • 8.3.13. Dragerwerk AG & Co. KGaA
      • 8.3.13.1. Company overview
      • 8.3.13.2. Financial performance
      • 8.3.13.3. Product benchmarking
      • 8.3.13.4. Strategic initiatives
    • 8.3.14. Bio-Rad Laboratories, Inc.
      • 8.3.14.1. Company overview
      • 8.3.14.2. Financial performance
      • 8.3.14.3. Product benchmarking
      • 8.3.14.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America drug screening market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America drug screening market, by product type, 2018 - 2030 (USD Million)
  • Table 4 North America drug screening market, by sample type, 2018 - 2030 (USD Million)
  • Table 5 North America drug screening market, by end-use, 2018 - 2030 (USD Million)
  • Table 6 U.S. drug screening market, by product type, 2018 - 2030 (USD Million)
  • Table 7 U.S. drug screening market, by sample type, 2018 - 2030 (USD Million)
  • Table 8 U.S. drug screening market, by end-use, 2018 - 2030 (USD Million)
  • Table 9 Canada drug screening market, by product type, 2018 - 2030 (USD Million)
  • Table 10 Canada drug screening market, by sample type, 2018 - 2030 (USD Million)
  • Table 11 Canada drug screening market, by end-use, 2018 - 2030 (USD Million)
  • Table 12 Mexico drug screening market, by product type, 2018 - 2030 (USD Million)
  • Table 13 Mexico drug screening market, by sample type, 2018 - 2030 (USD Million)
  • Table 14 Mexico drug screening market, by end-use, 2018 - 2030 (USD Million)
  • Table 15 Europe drug screening market, by region, 2018 - 2030 (USD Million)
  • Table 16 Europe drug screening market, by product type, 2018 - 2030 (USD Million)
  • Table 17 Europe drug screening market, by sample type, 2018 - 2030 (USD Million)
  • Table 18 Europe drug screening market, by end-use, 2018 - 2030 (USD Million)
  • Table 19 UK drug screening market, by product type, 2018 - 2030 (USD Million)
  • Table 20 UK drug screening market, by sample type, 2018 - 2030 (USD Million)
  • Table 21 UK drug screening market, by end-use, 2018 - 2030 (USD Million)
  • Table 22 Germany drug screening market, by product type, 2018 - 2030 (USD Million)
  • Table 23 Germany drug screening market, by sample type, 2018 - 2030 (USD Million)
  • Table 24 Germany drug screening market, by end-use, 2018 - 2030 (USD Million)
  • Table 25 France drug screening market, by product type, 2018 - 2030 (USD Million)
  • Table 26 France drug screening market, by sample type, 2018 - 2030 (USD Million)
  • Table 27 France drug screening market, by end-use, 2018 - 2030 (USD Million)
  • Table 28 Italy drug screening market, by product type, 2018 - 2030 (USD Million)
  • Table 29 Italy drug screening market, by sample type, 2018 - 2030 (USD Million)
  • Table 30 Italy drug screening market, by end-use, 2018 - 2030 (USD Million)
  • Table 31 Spain drug screening market, by product type, 2018 - 2030 (USD Million)
  • Table 32 Spain drug screening market, by sample type, 2018 - 2030 (USD Million)
  • Table 33 Spain drug screening market, by end-use, 2018 - 2030 (USD Million)
  • Table 34 Denmark drug screening market, by product type, 2018 - 2030 (USD Million)
  • Table 35 Denmark drug screening market, by sample type, 2018 - 2030 (USD Million)
  • Table 36 Denmark drug screening market, by end-use, 2018 - 2030 (USD Million)
  • Table 37 Sweden drug screening market, by product type, 2018 - 2030 (USD Million)
  • Table 38 Sweden drug screening market, by sample type, 2018 - 2030 (USD Million)
  • Table 39 Sweden drug screening market, by end-use, 2018 - 2030 (USD Million)
  • Table 40 Norway drug screening market, by product type, 2018 - 2030 (USD Million)
  • Table 41 Norway drug screening market, by sample type, 2018 - 2030 (USD Million)
  • Table 42 Norway drug screening market, by end-use, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific drug screening market, by region, 2018 - 2030 (USD Million)
  • Table 44 Asia Pacific drug screening market, by product type, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific drug screening market, by sample type, 2018 - 2030 (USD Million)
  • Table 46 Aisa Pacific drug screening market, by end-use, 2018 - 2030 (USD Million)
  • Table 47 Japan drug screening market, by product type, 2018 - 2030 (USD Million)
  • Table 48 Japan drug screening market, by sample type, 2018 - 2030 (USD Million)
  • Table 49 Japan drug screening market, by end-use, 2018 - 2030 (USD Million)
  • Table 50 China drug screening market, by product type, 2018 - 2030 (USD Million)
  • Table 51 China drug screening market, by sample type, 2018 - 2030 (USD Million)
  • Table 52 China drug screening market, by end-use, 2018 - 2030 (USD Million)
  • Table 53 India drug screening market, by product type, 2018 - 2030 (USD Million)
  • Table 54 India drug screening market, by sample type, 2018 - 2030 (USD Million)
  • Table 55 India drug screening market, by end-use, 2018 - 2030 (USD Million)
  • Table 56 Australia drug screening market, by product type, 2018 - 2030 (USD Million)
  • Table 57 Australia drug screening market, by sample type, 2018 - 2030 (USD Million)
  • Table 58 Australia drug screening market, by end-use, 2018 - 2030 (USD Million)
  • Table 59 South Korea drug screening market, by product type, 2018 - 2030 (USD Million)
  • Table 60 South Korea drug screening market, by sample type, 2018 - 2030 (USD Million)
  • Table 61 South Korea drug screening market, by end-use, 2018 - 2030 (USD Million)
  • Table 62 Thailand drug screening market, by product type, 2018 - 2030 (USD Million)
  • Table 63 Thailand drug screening market, by sample type, 2018 - 2030 (USD Million)
  • Table 64 Thailand drug screening market, by end-use, 2018 - 2030 (USD Million)
  • Table 65 Latin America drug screening market, by region, 2018 - 2030 (USD Million)
  • Table 66 Latin America drug screening market, by product type, 2018 - 2030 (USD Million)
  • Table 67 Latin America drug screening market, by sample type, 2018 - 2030 (USD Million)
  • Table 68 Latin America drug screening market, by end-use, 2018 - 2030 (USD Million)
  • Table 69 Brazil drug screening market, by product type, 2018 - 2030 (USD Million)
  • Table 70 Brazil drug screening market, by sample type, 2018 - 2030 (USD Million)
  • Table 71 Brazil drug screening market, by end-use, 2018 - 2030 (USD Million)
  • Table 72 Argentina drug screening market, by product type, 2018 - 2030 (USD Million)
  • Table 73 Argentina drug screening market, by sample type, 2018 - 2030 (USD Million)
  • Table 74 Argentina drug screening market, by end-use, 2018 - 2030 (USD Million)
  • Table 75 MEA drug screening market, by region, 2018 - 2030 (USD Million)
  • Table 76 MEA drug screening market, by product type, 2018 - 2030 (USD Million)
  • Table 77 MEA drug screening market, by sample type, 2018 - 2030 (USD Million)
  • Table 78 MEA drug screening market, by end-use, 2018 - 2030 (USD Million)
  • Table 79 South Africa drug screening market, by product type, 2018 - 2030 (USD Million)
  • Table 80 South Africa drug screening market, by sample type, 2018 - 2030 (USD Million)
  • Table 81 South Africa drug screening market, by end-use, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia drug screening market, by product type, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia drug screening market, by sample type, 2018 - 2030 (USD Million)
  • Table 84 Saudi Arabia drug screening market, by end-use, 2018 - 2030 (USD Million)
  • Table 85 UAE drug screening market, by product type, 2018 - 2030 (USD Million)
  • Table 86 UAE drug screening market, by sample type, 2018 - 2030 (USD Million)
  • Table 87 UAE drug screening market, by end-use, 2018 - 2030 (USD Million)
  • Table 88 Kuwait drug screening market, by product type, 2018 - 2030 (USD Million)
  • Table 89 Kuwait drug screening market, by sample type, 2018 - 2030 (USD Million)
  • Table 90 Kuwait drug screening market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Drug screening market: market outlook
  • Fig. 14 Drug screening competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Drug screening market driver impact
  • Fig. 18 Drug screening market restraint impact
  • Fig. 19 Drug screening market: Product type movement analysis
  • Fig. 20 Drug screening market: Product type outlook and key takeaways
  • Fig. 21 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Immunoassays analyzers market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Chromatography instruments market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Breath analyzers market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Fuel cell breath analyzers market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Semi-conductor breath analyzers market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Others breath analyzers market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Rapid testing devices estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Urine testing devices estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Drug testing cups estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Dip cards estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Drug testing cassettes estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Oral fluid testing devices estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Consumables estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Assay kits estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Sample collection devices estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Calibrators & controls estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Other consumables estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Services and others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Drug screening market: Sample type movement analysis
  • Fig. 41 Drug screening market: Sample type outlook and key takeaways
  • Fig. 42 Urine samples market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 Breath samples estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Oral fluid samples market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 Hair samples estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 Other samples estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 Drug screening market: End-use movement analysis
  • Fig. 48 Drug screening market: End-use outlook and key takeaways
  • Fig. 49 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 Criminal justice and law enforcement agencies estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 Workplaces market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 Drug treatment centers market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 Individual users market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Pain management centers market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 Schools & colleges market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 57 Global drug screening market: Regional movement analysis
  • Fig. 58 Global drug screening market: Regional outlook and key takeaways
  • Fig. 59 Global drug screening market share and leading players
  • Fig. 60 North America, by country
  • Fig. 61 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 U.S. key country dynamics
  • Fig. 63 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Canada key country dynamics
  • Fig. 65 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Mexico key country dynamics
  • Fig. 67 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 UK key country dynamics
  • Fig. 70 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Germany key country dynamics
  • Fig. 72 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 France key country dynamics
  • Fig. 74 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 75 Italy key country dynamics
  • Fig. 76 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 77 Spain key country dynamics
  • Fig. 78 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 Denmark key country dynamics
  • Fig. 80 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 81 Sweden key country dynamics
  • Fig. 82 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 83 Norway key country dynamics
  • Fig. 84 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 85 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 86 Japan key country dynamics
  • Fig. 87 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 88 China key country dynamics
  • Fig. 89 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 90 India key country dynamics
  • Fig. 91 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 92 Australia key country dynamics
  • Fig. 93 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 94 South Korea key country dynamics
  • Fig. 95 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 96 Thailand key country dynamics
  • Fig. 97 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 98 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 99 Brazil key country dynamics
  • Fig. 100 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 101 Argentina key country dynamics
  • Fig. 102 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 103 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 104 South Africa key country dynamics
  • Fig. 105 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 106 Saudi Arabia key country dynamics
  • Fig. 107 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 108 UAE key country dynamics
  • Fig. 109 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 110 Kuwait key country dynamics
  • Fig. 111 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 112 Market share of key market players- Global drug screening market